Xgeva 120 MG/1.7 ML vial 1.7ML
Ended Awarded
- Contract number
- SPE2DR26F18CD
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $68,660
Award facts
- Contract value 100% obligated
- $68,659.62 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $68,659.62 to AmerisourceBergen Drug Corp for the supply of XGEVA 120 MG/1.7 ML vials. This firm fixed-price, non-set-aside contract is scheduled for completion by November 17, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. XGEVA is a prescription medication used primarily in oncology and orthopedic treatment to prevent skeletal-related events in patients with bone metastases and other bone conditions, representing a specialized pharmaceutical product critical to military and federal healthcare operations.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999 global pharmaceutical support vehicle extending through December 2026. As a major pharmaceutical distributor and leading federal medical vendor, AmerisourceBergen Drug Corp supplies an extensive portfolio of brand-name and generic medications, vaccines, and medical devices to support military healthcare systems and other federal agencies including the Defense Health Agency and U.S. Coast Guard. The competitively awarded delivery order reflects the contractor's established capability to fulfill specialized pharmaceutical procurement requirements within the DLA's comprehensive medical supply chain infrastructure.
Quick answers
Who was awarded contract SPE2DR26F18CD?
SPE2DR26F18CD was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 14, 2025.
How much is contract SPE2DR26F18CD worth?
The government has obligated $68,660 on SPE2DR26F18CD.
Is contract SPE2DR26F18CD an order under another contract?
Yes. SPE2DR26F18CD is a delivery order under SPE2DR25D3301, an indefinite delivery contract.
Was contract SPE2DR26F18CD competed?
The extent of competition for SPE2DR26F18CD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award